add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Below the beltNational - - Nov 22, 2009 A non-cancerous condition called BPH (benign prostatic hyperplasia) is far more common, affecting up to four in 10 men over 65. ... Resistive index: A newly identified predictor of outcome of transurethral ...UroToday - Nov 26, 2009 A total of 572 men aged 51-85 years scheduled to undergo TURP for benign prostatic hyperplasia were prospectively enrolled, and 560 were ultimately ... Dendreon Receives FDA Acknowledgement of Complete ResponsePR Newswire (press release) - Nov 20, 2009 Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC). The FDA considers this to be a complete, ... HairDX (RxR) Genetic Test Helps Doctors Assess The Risk For Benign Prostatic ...NewsBlaze - Nov 17, 2009 Benign Prostatic Hyperplasia (BPH) is the age-related overgrowth of specific prostate tissues, which often progresses to enlargement of the prostate. ... Don't dismiss PSA test, urologists urge6minutes - - Nov 17, 2009 “There may be a way of eliminating the effect of transition-zone PSA by a baseline testing of all men before the development of benign prostatic hyperplasia ... Revisiting A Few Hot Biotech Stocks Of 2009RTT News - Nov 23, 2009 Provenge, an investigational vaccine for the treatment of prostate cancer, works by stimulating the immune system to recognize a protein known as the ... BPH Essential Treatment with Thermobalancing Therapy Restores Potency by Fine ...SBWire (press release) - Nov 24, 2009 Fine Treatment offers unique Device for Prostate Care which reduces symptoms of BPH - Benign Prostatic Hypertrophy, independently of the prostate enragement ... New EDM 165 - Treatment for Prostate Diseases DeHavilland (press release) (subscription) Committee For Medicinal Products For Human Use Summary Of Positive Opinion For ...PharmaLive.com (press release) - Nov 20, 2009 Blockade of α1A-adrenoreceptors causes smooth muscle in the prostate, bladder base, bladder neck, prostatic capsule and prostatic urethra to relax, ... Committee For Medicinal Products For Human Use Post-Authorisation Summary Of ... PharmaLive.com (press release) Committee For Medicinal Products For Human Use Summary Of Positive Opinion For ... PharmaLive.com (press release) GTx, Inc. Reports Third Quarter 2009 Corporate ResultsWELT ONLINE - Nov 9, 2009 Toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN): The last patient will complete the ... Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat ...UroToday - Nov 23, 2009 To compare the results of contrast-enhanced colour Doppler (CECD)-targeted prostate biopsy with a systematic 10-core grey-scale biopsy scheme in patients ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
